Functional expression of NF1 tumor suppressor protein: association with keratin intermediate filaments during the early development of human epidermis.
BACKGROUND
NF1 refers to type 1 neurofibromatosis syndrome, which has been linked with mutations of the large NF1 gene. NF1 tumor suppressor protein, neurofibromin, has been shown to regulate ras: the NF1 protein contains a GTPase activating protein (GAP) related domain which functions as p21rasGAP. Our studies have previously demonstrated that the NF1 protein forms a high affinity association with cytokeratin 14 during the formation of desmosomes and hemidesmosomes in cultured keratinocytes.


METHODS
The expression of NF1 protein was studied in developing human epidermis using western transfer analysis, indirect immunofluorescence, confocal laser scanning microscopy, immunoelectron microscopy, and in situ hybridization.


RESULTS
The expression of NF1 protein was noted to be highly elevated in the periderm at 8 weeks estimated gestational age (EGA) and in the basal cells at 8-14 weeks EGA. During this period, NF1 protein was associated with cytokeratin filaments terminating to desmosomes and hemidesmosomes. NF1 protein did not display colocalization with alpha-tubulin or actin of the cytoskeleton, or with adherens junction proteins.


CONCLUSIONS
These results depict an early fetal period when the NF1 tumor suppressor is abundantly expressed in epidermis and associated with cytokeratin filaments. This period is characterized by the initiation of differentiation of the basal cells, maturation of the basement membrane zone as well as accentuated formation of selected cellular junctions. NF1 tumor suppressor may function in the regulation of epidermal histogenesis via controlling the organization of the keratin cytoskeleton during the assembly of desmosomes and hemidesmosomes.
Department of Medical Biochemistry, University of Turku, Turku, Finland. marhen@utu.fi
Maria
M
Malminen
Sirkku
S
Peltonen
Jussi
J
Koivunen
Juha
J
Peltonen
D000328:Adult; D000818:Animals; D002478:Cells, Cultured; D004817:Epidermis / Q000196:embryology* / Q000378:metabolism*; D005455:Fluorescent Antibody Technique; D005865:Gestational Age; D006801:Humans; D017403:In Situ Hybridization; D007382:Intermediate Filaments / Q000378:metabolism*; D015603:Keratinocytes / Q000378:metabolism; D007633:Keratins / Q000378:metabolism*; D018613:Microscopy, Confocal; D016253:Microscopy, Immunoelectron; D025542:Neurofibromin 1 / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism
D025542:Neurofibromin 1; D012333:RNA, Messenger; D007633:Keratins